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ABSTRACT
Rpp20 and Rpp25 are two key subunits of the human
endoribonucleases RNase P and MRP. Formation of
an Rpp20–Rpp25 complex is critical for enzyme
function and sub-cellular localization. We present
the first detailed in vitro analysis of their
conformational properties, and a biochemical and
biophysical characterization of their mutual interac-
tion and RNA recognition. This study specifically
examines the role of the Rpp20/Rpp25 association
in the formation of the ribonucleoprotein complex.
The interaction of the individual subunits with the P3
arm of the RNase MRP RNA is revealed to be negli-
gible whereas the 1:1 Rpp20:Rpp25 complex binds
to the same target with an affinity of the order of nM.
These results unambiguously demonstrate that
Rpp20 and Rpp25 interact with the P3 RNA as a
heterodimer, which is formed prior to RNA binding.
This creates a platform for the design of future
experiments aimed at a better understanding of
the function and organization of RNase P and
MRP. Finally, analyses of interactions with deletion
mutant proteins constructed with successively
shorter N- and C-terminal sequences indicate that
the Alba-type core domain of both Rpp20 and Rpp25
contains most of the determinants for mutual asso-
ciation and P3 RNA recognition.
INTRODUCTION
Ribonucleoproteins (RNPs) are functional units formed
by the association of protein-coding and non-coding
RNAs with proteins. RNPs are involved in a large
spectrum of molecular activities and govern key cellular
functions such as gene expression and its regulation; the
signiﬁcance of their roles is emphasized by the many
diseases caused by mutations that disrupt either the
RNA or the protein component of the RNP, or the
factors required for their correct assembly (1–3). Several
RNPs are implicated in the biogenesis of RNA, including
the related endoribonucleases RNase mitochondrial RNA
processing (MRP) and RNase P, both composed of an
RNA molecule and several protein subunits. RNase
MRP, identiﬁed only in Eukarya, is involved in
pre-rRNA processing, in particular in the formation of
the mature 50-end of the 5.8S rRNA (4,5). Very recently,
however, a more prevalent role of RNase MRP in
ribosome biogenesis has emerged, speciﬁcally for entry
of 35S pre-rRNA processing into the canonical matura-
tion pathway (6). Despite its predominant localization in
the nucleolus (7–9), RNase MRP also functions
in mitochondrial DNA replication, by cleaving an
RNA primer required for this process (10), and it has
been shown to partake in the degradation of the mRNA
encoding the mitosis speciﬁc cyclin B2 in yeasts (11).
The signiﬁcance of RNase MRP’s role in human growth
and diﬀerentiation is substantiated by the link
between mutations in the human RNA subunit and the
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pleiotropic condition termed cartilage–hair hypoplasia
(CHH), a severe form of dwarﬁsm (12).
Unlike RNase MRP, RNase P is ubiquitous in all
domains of life; in all cases, it processes precursor tRNA
transcripts, removing the 50 leader sequences to generate
their 50 mature termini (13). Moreover, the Saccharomyces
cerevisiae enzyme has been shown to be involved in C/D
small nucleolar RNA (snoRNA) processing (14).
The RNA components of RNase MRP and P are essen-
tial for enzymatic activity and a high degree of similarity
has been found or predicted in their structural features
across species (15–22). Such structural correspondence
has prompted endorsement for an evolutionary relation
between RNase P and MRP, and in support of this
hypothesis both complexes have been found to share
many protein subunits that co-purify with respective
endoribonuclease activities (13,22,23). In particular, to
date up to 10 subunits have been identiﬁed in both
human enzymes (hPop1, Rpp38, Rpp21, Rpp29/hPop4,
hPop5, Rpp25, Rpp20, Rpp14, Rpp30, Rpp40), of
which nine have homologues in yeast; in addition,
RNase MRP from S. cerevisiae contains two speciﬁc
proteins: Smn1 and Rmp1, and reports are discordant as
to whether yeast Rpp21 (Rpr2) is unique to RNase P
(22,24–27). Although in eukaryotes the RNA moieties of
RNase P and MRP are thought to embody the catalytic
core of the respective enzymes, they are reliant on the
protein subunits for function in vitro and in vivo (13,24).
The speciﬁc reasons for this requirement remain however
unknown; alleged roles of the protein components, that
await to be demonstrated, include maintaining the
correct and active 3D fold of the RNA molecule,
determining sub-cellular localization and contributing to
substrate RNA discrimination (13).
The elucidation of the overall composition and architec-
ture of the eukaryotic RNase P andMRP holoenzymes has
been stalled by the challenges encountered in the isolation
of the RNP complexes from native sources on the one
hand, and in obtaining pure, stable individual recombinant
components for reconstitution studies on the other (13). As
a ﬁrst step towards a depiction of the spatial organization
of the holoenzymes, binary interactions between protein
subunits, and with the RNA component, have been
investigated in both human and yeast systems (28–32).
However, such studies posed the question as to whether
the inconsistencies and lack of completeness encountered
in the investigations were a reﬂection of experimental arte-
facts, leading to false positive or false negative results.
First, numerous attempts foiled by technical diﬃculties in
obtaining recombinant proteins or by their high suscepti-
bility to misfold, aggregate, degrade or be altered by their
fusion tag have been reported (13,28,31,32); second, these
experiments suﬀer from the drawback that synergic actions
are not taken into account (13). The detailed molecular
interaction of some of the subunits has been well estab-
lished by structural data, in particular concerning the
archaeal proteins of RNase P (that have homologues in
eukaryotic systems) namely Rpp29–Rpp21 (33,34) and
Pop5–Rpp30 (35); however, to our knowledge no system-
atic biophysical analysis of eukaryotic subunits has been
reported thus far. We have therefore undertaken a
comprehensive biochemical and biophysical characteriza-
tion of two essential subunits of human RNase P and
MRP, namely Rpp20 and Rpp25, with the aim of under-
standing their molecular properties and identifying poten-
tial problems with the recombinant products that may
encumber assembly/interaction analyses. Rpp20 and
Rpp25 have been reported to associate stably with one
another and to interact with the P3 arm of the RNase
MRP RNA (25,31,36,37). We ﬁnd that Rpp20/Rpp25
association is very strong and that the heterodimerization
activity is located largely in the central Alba-type core
domain of both proteins. Importantly our results clearly
show that Rpp20 and Rpp25 operate in tandem and that
the formation of a 1:1 heterodimer is an obligate prereq-
uisite for RNA binding.
MATERIALS AND METHODS
Plasmid construction
The cDNAs of full-length human Rpp20 and Rpp25 in
pCR4_TOPO were used as templates for further cloning.
Rpp20 and Rpp25, and deletion mutants thereof were
subcloned in many diﬀerent expression vectors, but in
many cases the recombinant products turned out to be
insoluble, aggregated or aﬀected by their fusion tag. We
report here only the plasmids that have been utilized in
this work.
Full-length Rpp25 (encompassing residues 1–199) was
subcloned with an N-terminal hexahistidine tag into a
pPROEX-HTb expression vector (Invitrogen) using
Nco1/Not1 restriction sites. Full-length Rpp20 (residues
1–140) was subcloned by PCR into a pET-30 expression
vector using the LIC methodology (Novagen); the
pET-30 vector was modiﬁed to bear a TEV cleavage
site to remove the N-terminal hexahistidine tag.
Rpp20(35–140) was ampliﬁed from pET-30 Rpp20 by
PCR to introduce 50 Asc1 and 30 Not1 sites and then
ligated into a modiﬁed version of pET-15b vector
(Novagen) with an Asc1 site inserted directly after the
his tag.
Fragments subcloned in pETDuet-1 vector (Novagen)
with an N-terminal hexahistidine tag were: Rpp20,
Rpp20(16–140), Rpp25(25–170) and co-expressed
Rpp20/Rpp25 (in which Rpp20 bears the his tag).
Rpp25(25–170) was also subcloned in a pCDFDuet-1
vector (Novagen) also with an N-terminal hexahistidine
tag (Supplementary Data). For cloning into pETDuet-1
and pCDFDuet-1, PCR primers were designed to comple-
ment appropriate regions of DNA in the pET-30 and
pPROEX-htb clones encoding Rpp20 and Rpp25
proteins, respectively. Forward PCR primers used for
producing his-tagged proteins encoded a TEV-cleavage
site (ENLYFQG). Restriction sites incorporated in the
forward/reverse PCR primers were as follows: EcoRI/
NotI for Rpp20 and Rpp20(16–140); EcoRI/PstI for
Rpp25(25–170); DNA encoding non-his-tagged proteins
was ampliﬁed by PCR forward/reverse primers with
restriction sites NdeI/XhoI. PCR products were cut with
the appropriate restriction enzymes and ligated into simi-
larly digested pETDuet-1 or pCDFDuet-1. Escherichia
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coli KRX cells (Promega) were transformed with the
ligation mixtures and transformants, obtained on LB
amp plates (for pETDuet-1 clones) or LB streptomycin
plates (for pCDFDuet-1 clones), were screened by
colony PCR and recombinant clones were sequenced.
Protein expression and puriﬁcation
Rpp25, Rpp20 (from pET-30 vector) and Rpp20(35–140)
were expressed in E. coli strain BL21(DE3)pLysS at 37
and 18C, respectively, induced with 1mM IPTG
(isopropyl b-D-thiogalactoside) at an OD600 of 0.6 and
incubated for a further 3 h. All the other proteins
subcloned into pETDuet-1 or pCDFDuet-1 vectors were
expressed in E. coli KRX strain at 25C, induced using
1mM IPTG and 0.1% (w/v) rhamnose at an OD600 of
0.6 and incubated overnight.
Cell pellets were lysed by sonication in 20mM sodium
phosphate, 500mM NaCl, 20mM imidazole, pH 7.4 and
centrifuged to separate the soluble and insoluble fractions
of the cell. All recombinant proteins listed above were
soluble except Rpp20 expressed in pET-30. In this case,
the insoluble fraction of the pellet was completely
denatured in a buﬀer containing 8M urea (see below).
As all the soluble recombinant proteins contained a
hexahistidine-tag, or were co-expressed with
hexahistidine-tag proteins, they were puriﬁed by aﬃnity
chromatography on 5ml HisTrap columns (GE
Healthcare) with a gradient of 20–500mM imidazole.
The His-aﬃnity tag was removed by addition of TEV
protease and incubation at 30C overnight in 25mM
sodium phosphate, 100mM NaCl, 1mM DTT
(Dithiothreitol), pH 7; the reaction mixture was
subsequently applied to a Ni–NTA column (Qiagen) to
remove the cleaved tags, the His-tagged TEV and any
undigested product. The proteins were further puriﬁed
on a 5ml Hi-Trap heparin column, mainly to remove
nucleic acids contaminants. The proteins eluted with a
linear 0–2M NaCl gradient were dialysed overnight in
buﬀer A [phosphate buﬀered saline (PBS, Sigma) contain-
ing 10mM phosphate, 2.7mM KCl and 137mM NaCl,
adjusted to pH 7, plus 1mM DTE (Dithioerythritol)]
and loaded on a SuperdexTM 75 column in the same
buﬀer (see below). The tag was not removable for
Rpp20(35–140).
The cell pellet containing Rpp20 expressed from pET-30
vector was lysed by sonication in 20mM sodium phos-
phate, 500mM NaCl, 20mM imidazole, pH 7.4. After
centrifugation, the pellet containing inclusion bodies was
resuspended in 100mM sodium phosphate, 20mM
imidazole, 8M urea, pH 7 and then ﬁltered through a
0.2mm ﬁlter. The protein was puriﬁed on a 5ml HisTrap
column (GE Healthcare) under denaturing conditions
with a 20–500mM imidazole gradient. Rpp20 was then
refolded by stepwise dialysis as follows: the eluted
protein was placed in a dialysis membrane with molecular
weight cut-oﬀ of 6000Da and equilibrated for 24 h in a
base buﬀer (0.4M L-Arginine, 25mM sodium phosphate,
100mM NaCl, 1mM DTE, pH 7) containing 4M urea at
4C. Denaturant was slowly removed by a series of over-
night equilibrations with buﬀers of decreasing urea
concentration (2, 1, 0M). Finally, the sample was
dialysed into TEV protease buﬀer for removal of the
tag. Subsequent puriﬁcation steps were as described for
the other proteins. The correct refolding of Rpp20 was
validated by CD analysis. When recombinant Rpp20 (in
pET-30 vector) was co-expressed with Rpp25(25–170) (in
pCDFDuet-1) for analytical ultracentrifugation (AUC)
studies (see below), the complex was found in the
soluble fraction and did not require refolding.
Protein concentrations were calculated based upon the
near-UV absorption (e280) using theoretical extinction
coeﬃcients derived from ExPASy (38).
Size exclusion chromatography
Size exclusion chromatography (SEC) was performed
using an AKTA Basic System (GE Healthcare) in combi-
nation with a SuperdexTM 75 column (10/300). All
samples were exchanged into identical buﬀer conditions
(buﬀer A). The column was calibrated using separate
injections of aprotinin (6.5 kDa), ribonuclease A
(13.7 kDa), carbonic anhydrase (29.0 kDa), ovalbumin
(44.0 kDa) and conalbumin (77.0 kDa) from the
Low Molecular Weight Gel Filtration Calibration Kit
(GE Healthcare) under the same buﬀer conditions.
RNA sample preparation
The P3 arm of RNase MRP RNA was purchased from
IBA GmbH (Go¨ttingen, Germany) and dissolved in buﬀer
A. The RNA were annealed by heating at 95C for 5min
followed by slow cooling to room temperature as
previously described (39). The concentration of the
dissolved oligonucleotide was evaluated by UV measure-
ment at 95C, using a molar extinction coeﬃcient at
260 nm calculated by the nearest-neighbour model
(463 700M1 cm1) (40).
Isothermal titration calorimetry
The protein and RNA solutions were prepared in buﬀer
A. Experiments titrating Rpp25 with Rpp20 (and deletion
mutants) were performed at three diﬀerent temperatures
(293, 298 and 303K) using a high-sensitivity ITC-200
microcalorimeter from Microcal (GE Healthcare).
RNA–protein titrations were carried out at 298K on an
ITC-200 microcalorimeter. Before each isothermal titra-
tion calorimetry (ITC) experiment, the pH of each
solution was checked, the reference cell was ﬁlled with
deionized water, and the protein solutions were degassed
for 2–5min to eliminate air bubbles. The ﬁrst addition was
executed only after achieving baseline stability.
Measurement from the ﬁrst injection was discarded from
the analysis of the integrated data, in order to avoid arte-
facts due to the diﬀusion through the injection port
occurring during the long equilibration period, locally
aﬀecting the protein concentration near the syringe
needle tip. To investigate protein–protein interactions, in
each titration volumes of 2 ml of a solution of Rpp20 or
mutants thereof at a concentration of 160–180 mM were
injected into a solution of Rpp25 or mutants thereof
(20 mM) in the same buﬀer, using a computer-controlled
40-ml microsyringe. For the RNA–protein studies, the P3
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RNA at a concentration of 170 mM was injected into a
solution containing individual proteins or their
pre-assembled complexes at a concentration of 20 mM in
buﬀer A. Notably, the titration of Rpp25 with Rpp20 was
also repeated in perchlorate buﬀer (25mM sodium phos-
phate, 10mM sodium perchlorate, 1mM DTE, pH 7) to
check any eﬀect of this buﬀer (used in the CD experi-
ments, see below) on protein behaviour. A spacing of
200 s between each injection was applied to enable the
system to reach the equilibrium. Heat produced by
titrant dilution was veriﬁed to be negligible by performing
a control experiment, titrating it into the buﬀer alone,
under the same conditions. Integrated heat data
obtained for the titrations were ﬁtted using a non-linear
least-squares minimization algorithm to a theoretical titra-
tion curve, using the MicroCal-Origin 7.0 software
package. H (reaction enthalpy change in kJmol1),
Kb (binding constant in M
1), and n (molar ratio
between the two proteins in the complex) were the ﬁtting
parameters. The reaction entropy was calculated using the
relationships G=RT lnKb (R=8.314 Jmol1K1,
T=298K) and G=H TDS. In addition, from
the experiments at diﬀerent temperatures (293, 298 and
303K), the change in heat capacity Cp
 upon binding
has been calculated as the resulting slope in a plot of H
versus the experimental temperature.
The Rpp20 self-association was characterized following
a dilution protocol (41), injecting 3 ml of a Rpp20 solution
at a concentration of 6 mM into the calorimetric cell con-
taining 200ml of buﬀer A at 298K. The resulting dissoci-
ation isotherm was interpolated using a non-linear
regression ﬁtting procedure based on a simple dissociation
model (Supplementary Data).
Circular dichroism spectroscopy
Simultaneous UV and circular dichroism (CD) spectra of
0.2mgml1 protein solutions were recorded on the
Applied Photophysics Ltd. Chirascan Plus Spectrometer
(Leatherhead, UK), continuously ﬂushed with nitrogen.
The molar ellipticity per mean residue, [y]
(deg cm2 dmol1), was calculated from the equation:
[y]= [y]obs (mrw)/10 lC, where [y]obs is the ellipticity
(deg), mrw is the mean residue molecular weight, C is the
protein concentration (gml1), and l is the optical path
length of the cell (cm). Rectangular Suprasil cells with 1
and 0.05 cm path lengths were employed to record spectra
in the regions between 400–230 and 260–180 nm, respec-
tively. The parameters used to acquire the spectra were:
spectral bandwidth of 1 nm, data step-size of 1 nm with a
time-per-data-point of 1.5 and 3.0 s in the near-UV and
the far-UV, respectively. All the spectra were baseline cor-
rected by subtracting the buﬀer spectrum. Experiments
were conducted in buﬀer A at 298K. The sodium
chloride content of many buﬀers absorbs light very
strongly below 200 nm making CD measurements below
200 nm very diﬃcult and secondary-structure analysis less
reliable (42). A full far-UV CD spectrum down to 180 nm
was only possible replacing NaCl with sodium perchlorate
in the buﬀer medium (see above). To estimate the
secondary structure content, curve ﬁtting was performed
using DICHROWEB (43).
Nuclear magnetic resonance spectroscopy
Recombinant 15N-labelled Rpp25 and Rpp25(25–170)
were prepared on minimal media as described previously
(44) and dissolved in buﬀer A at concentrations of 0.1–
0.3mM. Nuclear magnetic resonance (NMR) spectra were
recorded at 298K on a Bruker Avance spectrometer
operating at 16.4T equipped with a triple resonance
cryoprobe. Spectra were processed and analysed as
previously reported (44).
Analytical ultracentrifugation
Sedimentation equilibrium experiments were performed
using a Beckman Optima XL-A analytical ultracentrifuge
as described previously (45). Samples were prepared in
buﬀer A and data were acquired with an average of 25
absorbance measurements at a wavelength of 280 nm and
a radial spacing of 0.001 cm. Sedimentation equilibrium
experiments were performed at 4C and rotor speeds of
17 000, 14 500 and 12 000 rpm for both Rpp20 and
co-expressed Rpp20/Rpp25(25–170). Protein concentra-
tions were in the range of 15–30mM for Rpp20/
Rpp25(25–170) and 90–180mM for Rpp20. For data
analysis, the partial speciﬁc volumes ( v) and monomeric
molecular weights of the diﬀerent proteins were calculated
from amino acid composition using SEDNTERP
(http://www.rasmb.bbri.org/) and gave the following
values: Rpp20 from pETDuet-1 vector (0.7269 cm3 g1;
15 706Da); Rpp20/Rpp25(25–170) (0.7253 cm3 g1;
16026Da and 0.7303 cm3 g1; 15 435Da, respectively).
The solvent density (r) was calculated to be
1.00722 gml1 at 4C. The monomeric buoyant molecular
massM(1 v) was calculated to be: 4206 for Rpp20 from
pETDuet-1, 4319 for Rpp20 from pET-30 and 4081 for
Rpp25(25–170). Data for all concentrations and speeds
were analysed simultaneously using a range of models in
the Sigmaplot software package as described previously
(45). Residuals were calculated by subtracting the best ﬁt
of the model from the experimental data.
RESULTS
Domain analysis of Rpp20 and Rpp25
Rpp20 and Rpp25 are postulated to function in tandem
and to be components of both human RNase P and MRP
complex (25,31,36,37). Comparative genomics and
primary sequence proﬁle analysis have unveiled an evolu-
tionary connection for Rpp20, Rpp25 and the archaeal
protein Alba; in particular, the phylogenetic tree derived
from the alignment of the Alba domain has subdivided
this superfamily into two eukaryotic families (containing
Rpp20 and Rpp25 orthologues, respectively) and one
archaeal Alba family (46). The primary function
ascribed to Alba proteins relates to DNA packaging and
chromosomal organization in archaea, in an equivalent
role to that of eukaryotic histones (47). Structural
studies have unveiled a compact a/b fold for the Alba
Nucleic Acids Research, 2010, Vol. 38, No. 12 4055
domain with a topology akin to the C-terminal domain of
IF3 (48). Since the ﬁrst structure of the archaeal Alba1
was published by Wardleworth et al. (48), several struc-
tures have been determined for Alba1 and Alba2 from
diﬀerent organisms, and the ﬁrst structure available
within the eukaryotic subgroups belongs to the
At2g34160 protein from Arabidopsis thaliana, of
unknown function, which has not been characterized
beyond the deposition of the coordinates (PDB ID
2Q3V). The primary sequence alignment of Rpp20 and
Rpp25 with proteins of known structure (Figure 1) com-
plemented with their secondary-structure prediction
analysis [PredictProtein (49), data not shown] would
suggest the presence of an Alba-type core domain
ﬂanked by additional secondary-structure elements
and/or unstructured regions. Guided by such analyses,
we embarked on mutagenesis studies of Rpp20
and Rpp25 to identify regions required for their
domain stability, their mutual interaction and RNA
recognition.
Characterization of Rpp20
Human Rpp20 is a 16 kDa protein predicted to consist of
an Alba-like domain and an N-terminal tail. To charac-
terize the molecular properties of Rpp20, far-UV CD
analysis was applied to full-length protein (encompassing
residues 1–140) and to two truncated C-terminal
fragments, spanning amino acids 16–140 and 35–140,
Figure 1. Sequence alignment for the Alba superfamily of proteins. For the archaeal subgroup, all Alba proteins whose structures have been solved
to date are displayed; At2g34160 is an eukaryotic protein of this superfamily whose structure has been determined; human Rpp20 and Rpp25 are
shown together with their respective yeast homologues Pop7 and Pop6; human C9orf23, belonging to the subgroup of Rpp25, is also included. The
alignment was obtained using ClustalW2 (http://www.ebi.ac.uk/Tools/clustalw2/index.html). Invariant residues are boxed in black and conserved
residues are in grey. The secondary-structure elements found in the archaeal Alba proteins are superposed on the amino acid sequence. The topology
of all structures is b1a1b2a2b3b4, but the plant At2g34160 protein contains an additional a-helix in the C-terminal region (labelled a3). The loop
regions are labelled L1–L5. The protein species along with their gene identiﬁer are: ALBA1_Sso, Sulfolobus solfataricus, gi46397340; ALBA1_Ssh,
Sulfolobus shibatae, gi46397339; ALBA_Ph, Pyrococcus horikoshii, gi34582290; ALBA_Af, Archaeoglobus fulgidus, gi34810782; ALBA_Mj,
Methanocaldococcus jannaschii, gi40889143; ALBA2_Ap, Aeropyrum pernix, gi34582348; ALBA2_Ssh, Sulfolobus shibatae, gi157881229;
At2g34160_At, Arabidopsis thaliana, gi52696237; RPP20_Hs, Homo sapiens, gi153791431; POP7_Sc, Saccharomyces cerevisiae, gi6319644;
RPP25_Hs, Homo sapiens, gi74733233; C9orf23_Hs, Homo sapiens, gi55958109; POP6_Sc, Saccharomyces cerevisiae, gi1723656.
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henceforth referred to as Rpp20(16–140) and
Rpp20(35–140), respectively. The deletion mutants were
designed to retain the regions conserved within the
superfamily (46) (Figure 1), and presumably an intact
Alba-type domain. It is noteworthy that extensive molec-
ular biology and biochemistry work had to be devoted to
obtain reproducibly soluble and stable proteins (see
‘Materials and Methods’ section and below).
Far-UV CD spectral analyses indicated that Rpp20
adopts an a/b fold, compatible with the Alba structure,
alongside ﬂexible regions, and consists of 18% a-helix,
25% b-strand, 24% turns and 33% of disordered/other
structures (Figure 2). As the shape of the curves is very
similar for Rpp20 and its deletion mutants (Figure 2A),
the comparative CD study supports the hypothesis that
the folded core of the protein is retained in all the
constructs examined, and that the most N-terminal 34
residues are likely to be predominantly unstructured.
The secondary-structure content for the deletion mutants
of Rpp20, however, could not be estimated because of
the instability and aggregation of Rpp20(16–140) and
Rpp20(35–140) in perchlorate and other buﬀers tested
which would be transparent below 200 nm (see
‘Materials and Methods’ section).
During puriﬁcation of recombinant proteins, we noticed
that full-length Rpp20 and its deletion mutants
Rpp20(16–140) and Rpp20(35–140) eluted in SEC at
apparent molecular weights of about 47, 43 and 40 kDa,
respectively (Figure 3 and Table 1), indicating the
formation of oligomers in solution. Subsequent AUC
sedimentation equilibrium experiments on full-length
Rpp20 could not conﬁrm the presence of a single ideal
species, as systematic residuals were observed (Figure 3);
nevertheless, a good ﬁt was obtained with a model of
self-association and non-interacting mixtures, signifying
that under the conditions used Rpp20 exists primarily in
a homodimeric state, alongside small amounts of
contaminating aggregates not in equilibrium with the
dimer itself. This may be due to part of the protein irre-
versibly unfolding and associating during the AUC exper-
iments. Interestingly, most of the Alba proteins studied
also form dimers in solution.
Figure 2. Molecular characterization of Rpp20 and Rpp25. (A) Far-UV CD spectra of Rpp20 grey, straight line; Rpp20(35–140) grey, dotted line;
Rpp25 black, straight line; and Rpp25(25–170) black, dotted line. The spectra were acquired in buﬀer A (see ‘Materials and Methods’ section), pH 7
at 298K. Rpp20(35–140) contained a 20-residue N-terminal histidine tag. (B) Far-UV CD spectra of apo Rpp20 black, straight line; apo Rpp25
black, dotted line; Rpp20/Rpp25 complex at 1:1 molar ratio, grey, straight line; theoretical curve for the Rpp20/Rpp25 complex as a weighted sum of
the isolated curves, grey, dotted line. The spectra were recorded in 20mM sodium phosphate, 100mM sodium perchlorate, pH 7 at 298K. The
secondary-structure content estimated by DICROWEB CD spectra analysis gave the following values: Rpp20 (18% a; 25% b; 24% turn; 33%
irregular); Rpp25 (18% a; 22% b; 25% turn; 34% irregular). (C) [1H–15N] HSQC NMR spectra of Rpp25 and (D) Rpp25(25–170) recorded in buﬀer
A, at 16.4 T and 298K.
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The process of association of Rpp20 was
characterized further by conducting dilution experiments
using ITC, where the amount of heat measured
upon each injection is governed by the enthalpy change
of dissociation and the monomer–dimer equilibrium con-
stant (Supplementary Data) (41). Analysis of the data
Figure 3. Analysis of the oligomeric state of Rpp20, Rpp25 and their complexes. (A) Sedimentation equilibrium analytical ultracentrifugation data
for Rpp20, collected at 17 000 r.p.m. using protein concentrations of 90 mM (circles), 135mM (squares) and 180mM (triangles). The data curves were
simultaneously ﬁtted to a model of homodimer + non-interacting hexamer, with the residuals (B) randomly distributed around zero. Attempts to ﬁt
the data curves to a single species or to other models, for example to a monomer in equilibrium with a hexamer, gave poorer ﬁts as shown by the
residuals in (C) and (D), respectively. (E) Size exclusion chromatography elution proﬁles for apo proteins: Rpp20 black; Rpp20(16–140) blue;
Rpp20(35–140) olive; Rpp25 red; and Rpp25(25–170) wine. (F) Size exclusion chromatography elution proﬁles for complexes: [Rpp20-Rpp25]/P3
RNA orange; [Rpp20(35–140)–Rpp25(25–170)]/P3 RNA cyan; Rpp20/Rpp25 magenta; co-expressed Rpp20/Rpp25(25–170) green; Rpp20(35–140)/
Rpp25(25–170) purple. Formula and calculated molecular masses are shown in Table 1.
Table 1. Size exclusion chromatography elution values for Rpp20, Rpp25, their mutants and their complexes
Protein Formula MW (kDa) Calculated MW (kDa) Elution volume (ml)
Rpp20a 32.1 (16.0)a 47.1 10.30
Rpp20(16–140)a 28.1 (14.1)a 45.3 10.40
HisRpp20(35–140)a,b 26.4 (13.2)a 39.9 10.72
Rpp25 20.6 39.2 10.77
Rpp25(25–170) 15.4 20.7 12.39
Rpp20/Rpp25c 36.6 53.8 9.96
Rpp20/Rpp25(25–170)d 31.5 41.1 10.65
Rpp20(35–140)/Rpp25(25–170) 28.6 31.1 11.35
[Rpp20-Rpp25]/P3 RNA 52.5 71.4 9.24
[Rpp20(35–140)-Rpp25(25–170)]/P3 RNA 44.4 56.4 9.84
The calculated molecular weights were obtained as reported in the ‘Materials and Methods’ section. The formula molecular weights of the
complexes was reported considering 1:1 heterodimers for Rpp20:Rpp25 and mutants thereof, and 1:1:1 for Rpp20:Rpp25:P3 RNA (see text).
aFormula molecular weight of the homodimer, with the monomeric value in brackets.
bHis-tag was not removed (see ‘Materials and Methods’ section).
cIdentical values were found for complexes prepared by mixing separately made proteins and for complexes obtained by co-expressing
recombinant proteins (see ‘Materials and Methods’ section).
dComplex obtained by co-expression of recombinant subunits (see ‘Materials and Methods’ section).
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shown in Supplementary Figure S1 revealed an enthalpic
change of 20 kJmol1 and a derived association constant
of 8 105M1 (Supplementary Data).
Characterization of Rpp25
Human Rpp25 is a 20.6 kDa protein that belongs to the
eukaryotic group most divergent from the archaeal Alba
subfamily. A distinctive trait of Rpp25 and its orthologues
is the occurrence of a long C-terminal extension bearing
the conserved GYQXP signature (at position 150–154 in
human Rpp25), whose function remains unidentiﬁed.
Bioinformatic analyses of Rpp25 (Figure 1 and see
above) favour the presence of a putative Alba-type core
domain ﬂanked by N- and C-terminal extensions and to
characterize this further a number of deletion
mutants were designed accordingly. Nonetheless, for
several, the lack of expression or solubility of the
recombinant products, or else instability of the puriﬁed
proteins could not be overcome (data not shown), hence
eﬀorts converged towards the attainment of the
full-length protein and one deletion mutant truncated
at both N- and C-terminal tails, speciﬁcally Rpp25(25–
170).
To evaluate the eﬀects of such N- and C-terminal trun-
cations on the secondary structure of Rpp25, far-UV CD
spectra were recorded for the wild-type andRpp25(25–170)
mutant, revealing comparable curves for the two proteins
and bearing the hallmarks of a/b domains. Nonetheless, the
molar ellipticities are signiﬁcantly less negative for the
full-length Rpp25, in concomitance with the negative
peak shifted towards 200 nm. It is therefore conceivable
that longer Rpp25 has a lower amount of structured
content, supporting the notion of partially disordered N-
and C-terminal tails. Although a full secondary structure
content prediction for Rpp25(25–170) was impeded by the
poor behaviour of the protein in perchlorate buﬀer, the
qualitative CD results are in excellent agreement with the
NMR analysis: here the comparison of 1H–15N HSQC
spectra of full-length Rpp25 and its mutant Rpp25(25–
170) demonstrated that the well-dispersed resonances
belonging to the folded portion of the protein remain
unaltered in the shorter construct, plus the sharp signals
exclusive to the intact Rpp25 spectrum manifest a very
narrow range of chemical shifts, symptomatic of ﬂexible
conformations (50) (Figure 2).
On a size exclusion column, Rpp25 migrated with an
apparent molecular weight of 39 kDa; however, the par-
tially unstructured nature of the N- and C-terminal appen-
dices (see above) is expected to inﬂuence the eﬀective
hydrodynamic radius of the macromolecule, and may
therefore result in an overestimation of the protein mass
by this technique. Unfortunately, accurate determination
of the molecular weight using shape-independent AUC
equilibrium sedimentation was precluded by the inherent
instability of the full-length product at concentrations
required for this experiment over a period of 2–3 days.
Nonetheless, the presumably more globular mutant
Rpp25(25–170) (15.4 kDa), behaved plausibly as a
monomer on the SEC, with an apparent molecular mass
of 21 kDa (Figure 3 and Table 1). On the basis that
full-length Rpp25 elutes later than full-length Rpp20
from the size exclusion column in the same experimental
conditions (Figure 3), despite a greater formula molecular
weight and conceivably a less globular shape, we
concluded that Rpp25 in solution exists largely in a
monomeric state.
ITC experiments reveal a strong interaction between
Rpp25 and Rpp20
Despite earlier reports that Rpp20 and Rpp25 interact
strongly in vivo and in vitro, no quantitative measure of
this interaction has ever been reported. This would be
important to determine, with the aim of understanding
whether the two proteins are likely to operate as a single
working pair or act individually; also the analysis of the
energetics of the interaction might provide insights into
their mechanism of action. To this aim, we employed
ITC, which is largely used to investigate molecular
binding reactions by measuring the heat generated or
absorbed in the binding event and thereby providing the
binding constant, the molar ratio of the two proteins in
the complex and the enthalpy change (H) of the inter-
action. For the Rpp25–Rpp20 system the integrated heat
data, at each investigated temperature, showed that the
binding process is composed of one clear event centred
on a molar ratio of one (Figure 4). The binding
isotherm curves corresponding to this reaction have been
interpolated using an independent-sites model, revealing
that at 298K full-length proteins interact with each
other with an association constant (Kb) of 5.3 107M1,
with an enthalpy change (H) of 94 kJmol1 and an
entropic contribution (deﬁned as TDS) of 50 kJmol1.
The thermodynamics of the interaction indicate that the
binding event is enthalpically driven.
The N- and C-terminal regions of Rpp25 and the
N-terminal tail of Rpp20 are not involved in mutual
recognition
To delineate the regions of Rpp20 responsible for Rpp25
recognition, ITC measurements were carried out on the
deletion mutants Rpp20(16–140) and Rpp20(35–140)
truncated in the N-terminal tail. Interestingly, in both
cases the global thermodynamics of the interaction with
Rpp25 is seemingly unaﬀected (Table 2), suggesting that
the N-terminal region of Rpp20 does not participate in
this recognition.
A second set of experiments was performed monitoring
complex formation between the Rpp25(25–170) mutant
and all the available versions of Rpp20, to evaluate the
contribution to binding of the N- and C-terminal regions
of Rpp25 (Figure 4 and Table 2). The thermodynamic
signature of the association is fully preserved in all cases
(Table 2), thereby demonstrating that the elements
required for the mutual interaction remain intact in the
deletion mutants and that both the N- and C-terminal tails
of Rpp25 do not partake in the recognition process.
Furthermore, the Kb values obtained in the reactions
with the truncated Rpp25 mutant are slightly higher
than the ones found with full-length Rpp25, indicative
of an improved eﬃciency of the interaction and
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probably linked to the absence of the mainly unstructured
tails.
Taken together, the ITC experiments reveal that the
regions within the mutants Rpp20(35–140) and
Rpp25(25–170) are suﬃcient for mutual interaction,
indicating that this recognition could be mediated
largely, if not exclusively, by the Alba-type core domains.
In support, CD spectroscopy showed that the association
between Rpp20 and Rpp25 has no detectable inﬂuence on
their secondary/tertiary structure (Figure 2); in other
Figure 4. Analysis of Rpp20–Rpp25 complex formation. Raw titration data showing the thermal eﬀect of (A) injecting Rpp20 into a calorimetric cell
containing Rpp25 and (B) injecting Rpp20(35–140) into a calorimetric cell containing Rpp25(25–170). All the proteins were dissolved in buﬀer A. (C
and D) The normalized heat of interaction, for the titrations shown in (A) and (B), respectively, was obtained by integrating the raw data and
subtracting the heat of ligand dilution into the buﬀer alone. The grey line represents the best ﬁt obtained by a non-linear least-squares procedure
based on an independent binding sites model. (E) Sedimentation equilibrium analytical ultracentrifugation data for co-expressed Rpp20/Rpp25(25–
170), collected at protein concentration of 24 mM and three speeds: 17 000 r.p.m. (circles), 12 000 r.p.m. (squares) and 14 500 r.p.m. (triangles). The
data curves were simultaneously ﬁtted to a heterodimer + non-interacting hexamer model, with the residuals (F) randomly distributed around zero.
Attempts to ﬁt the data curves to a single species or to other models, for example to a mixture of non-interacting Rpp20 homodimers and Rpp25
monomers, gave poorer ﬁts as shown by the residuals in (G) and (H), respectively.
Table 2. Thermodynamic signature of the interactions between Rpp20 and Rpp25, their truncation mutants and the P3 RNA
Interaction n Kb (M
1) H (kJmol1) TDS (kJmol1) G (kJmol1)
Rpp25/Rpp20 0.8 5.3 107 94.1 50.0 44.1
Rpp25/Rpp20(16–140) 0.9 7.9 107 105.8 60.8 45.0
Rpp25/Rpp20(35–140) 0.9 3.2 107 98.7 55.9 42.8
Rpp25(25–170)/Rpp20 0.8 5.8 107 105.0 60.7 44.3
Rpp25(25–170)/Rpp20(16–140) 0.8 4.9 107 103.8 59.9 43.9
Rpp25(25–170)/Rpp20(35–140) 0.8 4.9 107 102.1 58.2 43.9
[Rpp25-Rpp20]/P3 RNA 0.9 1.3 107 27.6 13.0 40.6
[Rpp25(25–170)–Rpp20(35–140)]/P3 RNA 0.8 6.3 106 24.3 14.5 38.8
The reported values represent the average over three independent measurements and the error was found to be <5%.
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words, this interaction is not accompanied by structural
rearrangements, thus ruling out refolding events in the
N- and/or C-terminal extensions upon binding.
The association reaction results in a large loss of
solvent-accessible area
To investigate the Rpp20–Rpp25 interaction in more
depth, we measured the values for the change in heat
capacity Cp
 upon binding; these are all negative and
centred around 3 kJmol1K1 (Supplementary Table
S1). From the Cp
 values, an estimation of the
solvent-accessible surface area buried upon association
could in principle be derived; this however requires an
accurate determination of the ionization and protonation
contributions to the H, achieved by performing titra-
tion experiments in diﬀerent buﬀer/salt conditions (51).
Unfortunately, we could not ﬁnd a suﬃcient number of
experimental conditions for such measurements because of
protein misbehaviour. Nonetheless, the large negative
Cp
 values point towards a large loss of
solvent-accessible surface area upon complex formation,
suggesting that each protein participates in the association
through a large interacting surface. This ﬁnding is consis-
tent with the high values measured for the Kb.
Rpp20 and Rpp25 form a stable 1:1 heterodimer
ITC experiments indicate that Rpp20 and Rpp25 interact
with one another in a 1:1 molar ratio. Nonetheless, the
homodimeric nature of Rpp20 invites the question
whether the complex consists of a 1:1 (Rpp20/Rpp25)
heterodimer or a 2:2 (Rpp20/Rpp25) heterotetramer.
Understanding the exact stoichiometry of the Rpp20/
Rpp25 complex is a matter of key importance: since
many of the RNase P/MRP subunits do indeed
self-associate, it has been suggested that the holoenzyme(s)
might contain multiple copies of its constituents (13,26).
To address this point, AUC sedimentation equilibrium
experiments were attempted on a number of complexes
with various combinations of full-length and deletion
mutant proteins, including co-expressed recombinant frag-
ments. Some of the results, however, were ambiguous and
deemed inconclusive, once more thwarted by the high pro-
pensity of the complexes to aggregate and in some cases by
their susceptibility to degrade over a short period of time.
The best results were obtained for the co-expressed Rpp20/
Rpp25(25–170), though yet again the data did not corre-
spond to a single species but gave a reasonable ﬁt using a
model of self-association with non-interacting aggregates.
The best ﬁt was found for a 1:1 heterodimer in the presence
of, but not in equilibriumwith, other species of largermolec-
ular weight (Figure 4). Consistent with this, the pattern of
the SEC proﬁles clearly supports the Rpp20/Rpp25
heterodimer model, with apparent molecular masses of
their complexes (including a variety of combinations with
truncation mutants) well below the expected formula
weights for putative tetramers (Figure 3 and Table 1). This
not only implies a signiﬁcant overlap in the surfaces of
Rpp20 implicated in homodimerization and Rpp25
binding, but also that the two subunits are optimized to
maximize heterotypic complementarity. A quantitative
treatment of the equilibrium between the Rpp20
homodimer and the Rpp20/Rpp25 heterodimer revealed
that the preferential heterodimer formation arise from a
higher association constant of Rpp20/Rpp25 with respect
to the self-association of Rpp20 (Supplementary Data).
Interestingly, this closely resembles the molecular
behaviour of Alba1/Alba2 proteins, which form an
obligate heterodimer though existing individually as tight
homodimers (52). A 1:1 stoichiometry is also in agreement
with what was found for the yeast homologue Pop6/Pop7
complex (53), although theoligomeric state ofPop7 (homol-
ogous to Rpp20) was not characterized beyond observa-
tions of self-association in GST-pull down assays (32).
Rpp20 and Rpp25 interact with the P3 arm of RNase
MRP RNA in a highly synergic fashion
The Rpp20/Rpp25 complex and the isolated Rpp25 have
been reported to interact with the P3 arm of the RNase
MRP RNA (hereafter referred to as P3 RNA) (36,37). To
gain a better insight into the nature of these interactions,
we performed ITC titrations between the P3 RNA and an
array of Rpp20 and Rpp25 proteins and complexes. To
begin with, the RNA binding ability of the individual
full-length proteins was appraised: as shown in Figure 5,
the ITC results indicated that isolated Rpp20 was unable
to interact with P3 RNA, whereas Rpp25 displayed a
weak association, with a dissociation constant lower
than the threshold of binding that could be fully
characterized by ITC, i.e. around 0.1mM. Next, under
the same experimental conditions, we measured the
binding of a previously assembled Rpp20/Rpp25
complex with the P3 RNA (Figure 5 and Table 2): in
this case a much stronger interaction was detected, with
a binding aﬃnity of 1.3 107M1 and favourable changes
in enthalpy and entropy (asTDS) of 28 kJmol1 and
13 kJmol1, respectively. The negative enthalpy change
denotes the formation of new intermolecular contacts
between the protein complex and the RNA molecule,
whereas the negative entropic contribution suggests an
increased degree of freedom of the system upon binding,
probably because of displacement of bound water mole-
cules from interacting surfaces. It is noteworthy that, as
the protein concentrations used in the ITC measurements
are a 1000-fold higher than the Kd value describing
protein–protein binding, we anticipate that the Rpp20/
Rpp25 mixture would exist solely in the heterodimeric
form prior to RNA interaction, as conﬁrmed by gel ﬁltra-
tion analysis (Figure 5). Our results therefore reveal a
truly synergic mechanism by which heterodimer formation
augments the aﬃnity of the individual subunits for the P3
RNA by at least a 1000-fold, thereby conferring P3 RNA
binding proﬁciency to the Rpp20 and Rpp25 subunits.
The strong speciﬁc binding to the P3 stem–loop is in
complete agreement with previously reported GST
pull-down studies (36).
Thus it appears that the generation of the required
RNA-binding surface for this RNA target strictly hinges
on the heterodimerization of the protein subunits, and to
determine whether the partially disordered extensions of
Rpp20 and Rpp25 would participate in RNA interaction,
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a second set of ITC experiments using the truncated
heterodimer Rpp20(35–140)/Rpp25(25–170) was under-
taken. The results in Figure 5 and Table 2 show that
this complex binds to P3 RNA with slightly lower
aﬃnity than the full-length counterparts, suggesting that,
whereas the extensions beyond the domain core of Rpp20
and Rpp25 had essentially no eﬀect on protein–protein
interaction, they may well play a role in RNA recognition.
Nevertheless, since the decrease in RNA binding aﬃnity
exhibited by the deletion mutant complex is relatively
small, the core of the Rpp20/Rpp25 proteins plausibly
dominates the RNA interaction, with the tails only
yielding a minor contribution to stabilization of the
RNA complex.
Contrary to archaeal Alba proteins, which interact with
double stranded DNA at stoichiometries of 12 bp or 6 bp
per dimer (48,52), our isothermal binding curves clearly
indicate that each Rpp20/Rpp25 heterodimer binds to one
Figure 5. Rpp20/Rpp25 interaction with P3 RNA. Raw titration data showing the thermal eﬀect of 2 ml injections of 180mM P3 RNA into a
calorimetric cell ﬁlled with (A) 20 mM Rpp20; (B) 20 mM Rpp25; (C) 20 mM Rpp20/Rpp25 complex; and (D) 20 mM Rpp20(35–140)/Rpp25(25–170)
complex. All the molecules were dissolved in buﬀer A. The heat eﬀect reveals null to weak interactions in (A) and (B) and a strong association in (C)
and (D). (E–H) The normalized heat of interaction, for the titrations shown in (A–D), respectively, was obtained by integrating the raw data and
subtracting the heat of P3 RNA dilution into the buﬀer alone. The grey lines in G and H represent the best ﬁt derived by a non-linear least-squares
procedure based on an independent binding sites model. (I) Expected secondary structure of the P3 arm of the RNase MRP RNA obtained with the
software mfold (http://mobyle.pasteur.fr/cgi-bin/portal.py?form=mfold). (J) Gel ﬁltration elution proﬁles and SDS–PAGE analysis of Rpp20/Rpp25
(grey) and [Rpp20-Rpp25]/P3 RNA (black) complexes from the ITC experiment samples (see text).
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molecule of 50 nt P3 RNA. A stoichiometry of 1:1:1
(Rpp20:Rpp25:P3) agrees well with the size exclusion
proﬁles (Figure 3 and Table 1).
DISCUSSION
The purpose of this study was to shed light on the orga-
nization and function of the RNase P and MRP, in par-
ticular focussing on the essential Rpp20 and Rpp25
subunits. The recombinant proteins were subjected to an
array of biochemical and biophysical methodologies, with
the aim of understanding their molecular behaviour and
the details of molecular recognition within the RNP
complex. The value of these investigations is 2-fold: ﬁrst,
such molecular characterizations are per se key to eluci-
date RNP architecture and mode of action, and they are
generally not aﬀorded by studies on puriﬁed native parti-
cles; secondly, a detailed scrutiny of the molecular
behaviour of recombinant products could provide a
solid platform for the design of subsequent experiments.
It is noteworthy that a further dimension of complexity
and interest of these systems is the nearly identical com-
position of the protein subunit element for the RNase P
and MRP of a given organism, despite their distinctive
functions; furthermore, it was very recently reported that
the human RNase MRP RNA associates with the
telomerase reverse transcriptase to generate an RNP
with RNA-dependent RNA polymerase activity (54).
This adds conviction to the view that the determinants
of the function for a given RNP particle reside in its
entirety, underscoring therefore the importance of
elucidating the molecular basis of recognition between
the diﬀerent components within the RNP systems.
Rpp20 and Rpp25 have previously been shown in vivo
and in vitro to associate with one another, with functional
relevance for holoenzyme association and localization
(36). Nonetheless, it remained unclear whether the
Rpp20/Rpp25 complex would constitute a single
working unit, in other words whether this complex
would represent the minimal protein and RNA-binding
unit within the RNP particle. Such a conclusion can in
fact only be derived from systematic biophysical and bio-
chemical analyses with multiple components, beyond the
largely qualitative screening of binary Rpp25–RNA and
Rpp20–RNA interactions hitherto reported
(31,36,37,55,56). Although Rpp20 has been said to have
the ability to enhance the interaction between Rpp25 and
the RNA (36,37), the results presented here ﬁrmly indicate
that Rpp20 and Rpp25 operate as a single working unit,
whereby their assembly is an obligate prerequisite for P3
RNA interaction. In fact, Rpp20–Rpp25 nanomolar dis-
sociation constant would strongly argue for a preponder-
ance of the heterodimeric form also in vivo, which agrees
well with particle composition analysis studies (31); in
addition, the ITC results unambiguously prove that the
binding to the P3 arm of the RNase MRP RNA is a
fully synergic event, with an association constant for the
complex at least a 1000-fold higher than for Rpp25 alone.
Given the similarity between the P3 domain of RNase P
and RNase MRP RNA, it is likely that the same
molecular recognition occurs in both holoenzymes. A
similar conclusion was also proposed for the yeast
homologues Pop6/Pop7, although the suggested synergic
mechanism here stopped short of full characterization
because of diﬃculties in obtaining both individual
proteins (53).
The detailed molecular explanation for such synergic
behaviour remains to be uncovered; nonetheless, our
current results point to the likelihood that the interface
required for P3 RNA binding is generated upon the for-
mation of the heterodimer. The bioinformatic analysis in
conjunction with the CD and ITC investigations presented
here show that Rpp20 and Rpp25 contain a core
Alba-type domain ﬂanked by extensions (N-terminal for
Rpp20 and N- and C-terminal for Rpp25) which do not
contribute to core domain stabilization or to protein–
protein interaction, but may play a minor role in RNA
recognition. Speciﬁcally, our study explored whether trun-
cation of these extensions aﬀected the structural and func-
tional properties relative to the wild-type. As none of the
mutants analysed elicit structural alterations or exhibited
diﬀerences in mutual recognition compared to the
full-length proteins, we reason that the extensions are
probably largely unstructured and that Rpp20 and
Rpp25 interact with one another mainly through the
Alba-type core domain without undergoing substantial
conformational rearrangements, forming a tight 1:1
heterodimer. Within the structure catalogue of archaeal
Alba proteins, the heterodimeric organization is
exempliﬁed by the Alba1/Alba2 complex from Sulfolobus
solfataricus (52) (Figure 6).
This quaternary arrangement exhibits a high degree of
conservation amongst the homodimeric archaeal Alba
structures and, interestingly, is extremely similar to the
very recent structure of the yeast Pop6/Pop7 heterodimer
bound to the P3 arm of the yeast RNase MRP (57). The
protein–protein interface in these complexes is formed by
helix a2 and the last two b-strands (b3 and b4) from both
monomers, engaging in an extensive network of
hydrophobic interactions and speciﬁc hydrogen bond
contacts (Figure 6). Our results would support an
overall structural resemblance between Rpp20/Rpp25
and the yeast homologue system: akin to Pop6/Pop7,
Rpp20 and Rpp25 in fact interact with one another via
the Alba-like domain with a very extensive
solvent-accessible surface area buried by this molecular
association, as suggested by our ITC experiments (specif-
ically the large negative Cp
 values). Interestingly, Pop6
and Pop7 displayed an Alba-type domain fold with addi-
tional short secondary-structure elements in the
N-terminal region (in particular a b-strand and an
a-helix) (57); whether this is also the case for Rpp20 and
Rpp25 remains to be established. Bioinformatics analysis,
however, shows that for Pop6 these elements are
comprised in a region not present at all in Rpp25
[Figure 1 and ref. (57)], whereas a very low degree of con-
servation is displayed in this amino acid stretch for Pop7
and Rpp20 [Figure 1 and ref. (57)].
The Rpp20/Rpp25 heterodimer has been shown to
interact with the P3 RNA with a 1:1 stoichiometry, in
contrast with the situation in archaeal proteins where
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the binding to DNA entails a much higher protein:nucleic
acid ratio. This divergence though is not entirely unex-
pected, and conforms to Alba’s main role in DNA
packaging and organization. One may speculate that the
Rpp20/Rpp25 heterodimer would exhibit a nucleic acid
binding mechanism distinct from that of archaeal
homologues, following modiﬁcations in the course of evo-
lution in response to diﬀerent functional requirements.
Consistent with this idea, the recent evidence for the
yeast system showed that Pop6/Pop7 recognize speciﬁcally
a stem-bulge element in yeast P3 RNase MRP RNA (57)
compared to the non-speciﬁc double-helix DNA recogni-
tion which is characteristic of Alba.
Although the binding to the P3 RNA appears to be the
key factor in mediating the association of Rpp20 and
Rpp25 to the holoenzyme, previous work has suggested
that other protein subunits might further stabilize their
assembly into the RNP complex (31). Nonetheless, these
investigations through binary screening might not provide
a faithful reﬂection of the molecular recognition process in
the context of the holoenzymes, where synergic interac-
tions are likely to take place. In the case of Rpp20 and
Rpp25, our results clearly indicate that the outcome of
some of the previous investigations might have been per-
turbed because the interacting entities used were the indi-
vidual proteins instead of the working unit deﬁned as a
pair, and the isolated proteins may be unlikely to retain
authentic binding behaviour. Crucially, it may also appear
that this is not a prerogative of Rpp20–Rpp25, as other
pairs which are likely to perform as a working unit have
already been identiﬁed, namely Rpp29–Rpp21 (33,34) and
Pop5–Rpp30 (35), although this remains to be conﬁrmed
by quantitative measurements of their association. The
identiﬁcation of pair-wise interactions between subunits
represents an important step forward in the study of the
assembly, structure and dynamics of the RNase P and
MRP holoenzymes.
In conclusion, the biochemical and biophysical charac-
terization of Rpp20 and Rpp25, and their interaction with
RNA will help elucidate the mechanistic basis of their
actions and will be an invaluable contribution to under-
standing the architecture and function of the eukaryotic
RNase P and MRP.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We are grateful to the MRC Biomedical NMR Centre,
Mill Hill and its staﬀ, for a generous allocation of NMR
time and for expert technical assistance. We thank Drs
Tim Welting and Sandy Mattijssen for helpful discussions.
FUNDING
The Wellcome Trust for the Biomolecular Centre for
Molecular Spectroscopy (to M.R.C., A.F.D.);
EPSRC-case PhD studentship (to K.L.D.H-T.). Funding
for open access charge: The Wellcome Trust.
Conﬂict of interest statement. None declared.
REFERENCES
1. Lukong,K.E., Chang,K.W., Khandjian,E.W. and Richard,S.
(2008) RNA-binding proteins in human genetic disease.
Trends Genet., 24, 416–425.
2. Cooper,T.A., Wan,L. and Dreyfuss,G. (2009) RNA and disease.
Cell, 136, 777–793.
3. Glisovic,T., Bachorik,J.L., Yong,J. and Dreyfuss,G. (2008)
RNA-binding proteins and post-transcriptional gene regulation.
FEBS Lett., 582, 1977–1986.
4. Schmitt,M.E. and Clayton,D.A. (1993) Nuclear RNase MRP is
required for correct processing of pre-5.8S rRNA in
Saccharomyces cerevisiae. Mol. Cell Biol., 13, 7935–7941.
5. Lygerou,Z., Allmang,C., Tollervey,D. and Seraphin,B. (1996)
Accurate processing of a eukaryotic precursor ribosomal RNA by
ribonuclease MRP in vitro. Science, 272, 268–270.
6. Lindahl,L., Bommankanti,A., Li,X., Hayden,L., Jones,A.,
Khan,M., Oni,T. and Zengel,J.M. (2009) RNase MRP is required
for entry of 35S precursor rRNA into the canonical processing
pathway. RNA, 15, 1407–1416.
7. Reimer,G., Raska,I., Scheer,U. and Tan,E.M. (1988)
Immunolocalization of 7-2-ribonucleoprotein in the granular
component of the nucleolus. Exp. Cell Res., 176, 117–128.
8. Gill,T., Aulds,J. and Schmitt,M.E. (2006) A specialized processing
body that is temporally and asymmetrically regulated during the
cell cycle in Saccharomyces cerevisiae. J. Cell Biol., 173, 35–45.
9. Kiss,T., Marshallsay,C. and Filipowicz,W. (1992) 7-2/MRP RNAs
in plant and mammalian cells: association with higher order
structures in the nucleolus. EMBO J., 11, 3737–3746.
10. Chang,D.D. and Clayton,D.A. (1987) A novel endoribonuclease
cleaves at a priming site of mouse mitochondrial DNA
replication. EMBO J., 6, 409–417.
11. Gill,T., Cai,T., Aulds,J., Wierzbicki,S. and Schmitt,M.E. (2004)
RNase MRP cleaves the CLB2 mRNA to promote cell cycle
progression: novel method of mRNA degradation. Mol. Cell
Biol., 24, 945–953.
Figure 6. Heterodimer interface analysis for the Alba superfamily of
proteins. Ribbon diagram showing the crystal structure of the Alba1/
Alba2 complex (PDB ID 2BKY). The secondary-structure elements are
indicated. The structure has been displayed using PyMol (http://www
.pymol.org/). The solvent-accessible surface area buried by heterodimer
formation was calculated by PyMol to be 1384 A˚2.
4064 Nucleic Acids Research, 2010, Vol. 38, No. 12
12. Ridanpa¨a¨,M., van Eenennaam,H., Pelin,K., Chadwick,R.,
Johnson,C., Yuan,B., vanVenrooij,W., Pruijn,G., Salmela,R.,
Rockas,S. et al. (2001) Mutations in the RNA component of
RNase MRP cause a pleiotropic human disease, cartilage-hair
hypoplasia. Cell, 104, 195–203.
13. Walker,S.C. and Engelke,D.R. (2006) Ribonuclease P: the
evolution of an ancient RNA enzyme. Crit. Rev. Biochem.
Mol. Biol., 41, 77–102.
14. Coughlin,D.J., Pleiss,J.A., Walker,S.C., Whitworth,G.B. and
Engelke,D.R. (2008) Genome-wide search for yeast RNase P
substrates reveals role in maturation of intron-encoded box C/D
small nucleolar RNAs. Proc. Natl Acad. Sci. USA, 105,
12218–12223.
15. Li,X., Frank,D.N., Pace,N., Zengel,J.M. and Lindahl,L. (2002)
Phylogenetic analysis of the structure of RNase MRP RNA in
yeasts. RNA, 8, 740–751.
16. Walker,S.C. and Avis,J.M. (2005) Secondary structure probing of
the human RNase MRP RNA reveals the potential for MRP
RNA subsets. Biochem. Biophys. Res. Commun., 335, 314–321.
17. Walker,S.C., Aspinall,T.V., Gordon,J.M. and Avis,J.M. (2005)
Probing the structure of Saccharomyces cerevisiae RNase MRP.
Biochem. Soc. Trans., 33, 479–481.
18. Reddy,R. and Shimba,S. (1995) Structural and functional
similarities between MRP and RNase P. Mol. Biol. Rep., 22,
81–85.
19. Forster,A.C. and Altman,S. (1990) Similar cage-shaped structures
for the RNA components of all ribonuclease P and ribonuclease
MRP enzymes. Cell, 62, 407–409.
20. van Eenennaam,H., Jarrous,N., van Venrooij,W.J. and Pruijn,G.J.
(2000) Architecture and function of the human endonucleases
RNase P and RNase MRP. IUBMB Life, 49, 265–272.
21. Jarrous,N. (2002) Human ribonuclease P: subunits, function, and
intranuclear localization. RNA, 8, 1–7.
22. Lopez,M.D., Rosenblad,M.A. and Samuelsson,T. (2009)
Conserved and variable domains of RNase MRP RNA.
RNA Biol., 6, 208–220.
23. Woodhams,M.D., Stadler,P.F., Penny,D. and Collins,L.J. (2007)
RNase MRP and the RNA processing cascade in the eukaryotic
ancestor. BMC Evol. Biol., 7, S13.
24. Chamberlain,J.R., Lee,Y., Lane,W.S. and Engelke,D.R. (1998)
Puriﬁcation and characterization of the nuclear RNase P
holoenzyme complex reveals extensive subunit overlap with
RNase MRP. Genes Dev., 12, 1678–1690.
25. Welting,T.J., Kikkert,B.J., van Venrooij,W.J. and Pruijn,G.J.
(2006) Diﬀerential association of protein subunits with the human
RNase MRP and RNase P complexes. RNA, 12, 1373–1382.
26. Salinas,K., Wierzbicki,S., Zhou,L. and Schmitt,M.E. (2005)
Characterization and puriﬁcation of Saccharomyces cerevisiae
RNase MRP reveals a new unique protein component.
J. Biol. Chem., 280, 11352–11360.
27. Schmitt,M.E. and Clayton,D.A. (1994) Characterization of a
unique protein component of yeast RNase MRP: an
RNA-binding protein with a zinc-cluster domain. Genes Dev., 8,
2617–2628.
28. Houser-Scott,F., Xiao,S., Millikin,C.E., Zengel,J.M., Lindahl,L.
and Engelke,D.R. (2002) Interactions among the protein and
RNA subunits of Saccharomyces cerevisiae nuclear RNase P.
Proc. Natl Acad. Sci. USA, 99, 2684–2689.
29. Jiang,T. and Altman,S. (2001) Protein-protein interactions with
subunits of human nuclear RNase P. Proc. Natl Acad. Sci. USA,
98, 920–925.
30. Jiang,T., Guerrier-Takada,C. and Altman,S. (2001) Protein-RNA
interactions in the subunits of human nuclear RNase P. RNA, 7,
937–941.
31. Welting,T.J., van Venrooij,W.J. and Pruijn,G.J. (2004) Mutual
interactions between subunits of the human RNase MRP
ribonucleoprotein complex. Nucleic Acids Res., 32, 2138–2146.
32. Aspinall,T.V., Gordon,J.M., Bennett,H.J., Karahalios,P.,
Bukowski,J.P., Walker,S.C., Engelke,D.R. and Avis,J.M. (2007)
Interactions between subunits of Saccharomyces cerevisiae RNase
MRP support a conserved eukaryotic RNase P/MRP architecture.
Nucleic Acids Res., 35, 6439–6450.
33. Honda,T., Kakuta,Y., Kimura,K., Saho,J. and Kimura,M. (2008)
Structure of an archaeal homolog of the human protein complex
Rpp21-Rpp29 that is a key core component for the assembly of
active ribonuclease P. J. Mol. Biol., 384, 652–662.
34. Xu,Y., Amero,C.D., Pulukkunat,D.K., Gopalan,V. and
Foster,M.P. (2009) Solution structure of an archaeal RNase P
binary protein complex: formation of the 30-kDa complex
between Pyrococcus furiosus RPP21 and RPP29 is accompanied
by coupled protein folding and highlights critical features for
protein-protein and protein-RNA interactions. J. Mol. Biol., 393,
1043–1055.
35. Kawano,S., Nakashima,T., Kakuta,Y., Tanaka,I. and Kimura,M.
(2006) Crystal structure of protein Ph1481p in complex with
protein Ph1877p of archaeal RNase P from Pyrococcus horikoshii
OT3: implication of dimer formation of the holoenzyme. J. Mol.
Biol., 357, 583–591.
36. Welting,T.J., Peters,F.M., Hensen,S.M., van Doorn,N.L.,
Kikkert,B.J., Raats,J.M., van Venrooij,W.J. and Pruijn,G.J.
(2007) Heterodimerization regulates RNase MRP/RNase P
association, localization, and expression of Rpp20 and Rpp25.
RNA, 13, 65–75.
37. Welting,T.J., Mattijssen,S., Peters,F.M., van Doorn,N.L.,
Dekkers,L., van Venrooij,W.J., Heus,H.A., Bonafe,L. and
Pruijn,G.J. (2008) Cartilage-hair hypoplasia-associated mutations
in the RNase MRP P3 domain aﬀect RNA folding and
ribonucleoprotein assembly. Biochim. Biophys. Acta, 1783,
455–466.
38. Gasteiger,E., Gattiker,A., Hoogland,C., Ivanyi,I., Appel,R.D. and
Bairoch,A. (2005) In Walker,J.M. (ed.), The Proteomics Protocols
Handbook. Humana Press, NJ, pp. 571–607.
39. Conte,M.R., Conn,G.L., Brown,T. and Lane,A.N. (1997)
Conformational properties and thermodynamics of the RNA
duplex r(CGCAAAUUUGCG)2: comparison with the DNA
analogue d(CGCAAATTTGCG)2. Nucleic Acids Res., 25,
2627–2634.
40. SantaLucia,J. Jr, Allawi,H.T. and Seneviratne,P.A. (1996)
Improved nearest-neighbor parameters for predicting DNA duplex
stability. Biochemistry, 35, 3555–3562.
41. Burrows,S.D., Doyle,M.L., Murphy,K.P., Franklin,S.G.,
White,J.R., Brooks,I., McNulty,D.E., Scott,M.O., Knutson,J.R.,
Porter,D. et al. (1994) Determination of the monomer-dimer
equilibrium of interleukin-8 reveals it is a monomer at
physiological concentrations. Biochemistry, 33, 12741–12745.
42. Fox,M.F., Barker,B.E. and Hayon,E. (1978) Far-ultraviolet
solution spectroscopy of chloride ion. J. Chem. Soc., Faraday
Trans. 1, 74, 1776–1785.
43. Whitmore,L. and Wallace,B.A. (2004) DICHROWEB, an online
server for protein secondary structure analyses from circular
dichroism spectroscopic data. Nucleic Acids Res., 32,
W668–W673.
44. Martino,L., He,Y., Hands-Taylor,K.L., Valentine,E.R., Kelly,G.,
Giancola,C. and Conte,M.R. (2009) The interaction of the
Escherichia coli protein SlyD with nickel ions illuminates the
mechanism of regulation of its peptidyl-prolyl isomerase activity.
FEBS J., 276, 4529–4544.
45. Shi,J., Ghirlando,R., Beavil,R.L., Beavil,A.J., Keown,M.B.,
Young,R.J., Owens,R.J., Sutton,B.J. and Gould,H.J. (1997)
Interaction of the low-aﬃnity receptor CD23/Fc epsilonRII lectin
domain with the Fc epsilon3-4 fragment of human
immunoglobulin E. Biochemistry, 36, 2112–2122.
46. Aravind,L., Iyer,L.M. and Anantharaman,V. (2003) The two
faces of Alba: the evolutionary connection between proteins
participating in chromatin structure and RNA metabolism.
Genome Biol., 4, R64.
47. Sandman,K. and Reeve,J.N. (2000) Structure and functional
relationships of archaeal and eukaryal histones and nucleosomes.
Arch. Microbiol., 173, 165–169.
48. Wardleworth,B.N., Russell,R.J., Bell,S.D., Taylor,G.L. and
White,M.F. (2002) Structure of Alba: an archaeal chromatin
protein modulated by acetylation. EMBO J., 21, 4654–4662.
49. Rost,B., Yachdav,G. and Liu,J. (2004) The PredictProtein server.
Nucleic Acids Res., 32, W321–W326.
50. Jacks,A., Babon,J., Kelly,G., Manolaridis,I., Cary,P.D., Curry,S.
and Conte,M.R. (2003) Structure of the C-terminal domain of
human La protein reveals a novel RNA recognition motif
Nucleic Acids Research, 2010, Vol. 38, No. 12 4065
coupled to a helical nuclear retention element. Structure, 11,
833–843.
51. Xie,D. and Freire,E. (1994) Structure based prediction of protein
folding intermediates. J. Mol. Biol., 242, 62–80.
52. Jelinska,C., Conroy,M.J., Craven,C.J., Hounslow,A.M.,
Bullough,P.A., Waltho,J.P., Taylor,G.L. and White,M.F. (2005)
Obligate heterodimerization of the archaeal Alba2 protein with
Alba1 provides a mechanism for control of DNA packaging.
Structure, 13, 963–971.
53. Perederina,A., Esakova,O., Koc,H., Schmitt,M.E. and
Krasilnikov,A.S. (2007) Speciﬁc binding of a Pop6/Pop7
heterodimer to the P3 stem of the yeast RNase MRP and RNase
P RNAs. RNA, 13, 1648–1655.
54. Maida,Y., Yasukawa,M., Furuuchi,M., Lassmann,T.,
Possemato,R., Okamoto,N., Kasim,V., Hayashizaki,Y.,
Hahn,W.C. and Masutomi,K. (2009) An RNA-dependent RNA
polymerase formed by TERT and the RMRP RNA. Nature, 461,
230–235.
55. Guerrier-Takada,C., Eder,P.S., Gopalan,V. and Altman,S. (2002)
Puriﬁcation and characterization of Rpp25, an RNA-binding
protein subunit of human ribonuclease P. RNA, 8, 290–295.
56. Yuan,Y., Tan,E. and Reddy,R. (1991) The 40-kilodalton to
autoantigen associates with nucleotides 21 to 64 of human
mitochondrial RNA processing/7-2 RNA in vitro. Mol. Cell Biol.,
11, 5266–5274.
57. Perederina,A., Esakova,O., Quan,C., Khanova,E. and
Krasilnikov,A.S. (2010) Eukaryotic ribonucleases P/MRP: the
crystal structure of the P3 domain. EMBO J., 29, 761–769.
4066 Nucleic Acids Research, 2010, Vol. 38, No. 12
